Abstract:Objective To express extracellular domain ofvaricella-zoster virus (VZV) glycoprotein E (gE) in Escherichia coli and to evaluate its immunization efficacy.Methods The extracellular domain of VZV gE was codon optimized and cloned into the prokaryotic expression vector pET-48b.After sequencing identification,the vector was transformed into competent cell BL21 (DE3).Isopropyl β-D-thiogalactoside (IPTG) was used to induce the expression in E.coli.SDS-PAGE electrophoresis and western blot (WB) were used to identify the specificity.The target protein was purified and renatured by Ni2+-NTA column and was used to immunize Balb/c mice.ELISA was used to detect the specificity and titer of serum.Results The extracellular domain of VZV gE was successfully expressed as inclusion bodies,and the purity was about 90％ after purification and renaturation.WB indicated that VZV gE had good immunoreactivity.After immunizing mice,specific antibodies can be produced at the same level as the commercial live attenuated varicella vaccine.Conclusions The VZV gE protein was expressed in prokaryotic expression system successfully and its ability of inducing specific immune responses was confirmed.The study provides scientific basis for the development of VZV vaccine.

Prokaryotic Expression and Priliminary Evaluation of the Immunization Efficacy of Varicella-Zoster Virus Glycoprotein E